Levofloxacin Olikla

Levofloxacin, the active ingredient in Levofloxacin Olikla, is a fluoroquinolone antibiotic presented as a sterile ophthalmic solution for ocular use. It treats bacterial eye infections such as conjunctivitis, keratitis and post‑surgical infections in both adult and pediatric patients as prescribed by a qualified eye‑care professional.

GNH USA supplies Levofloxacin Olikla as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support global distribution, ensuring product integrity and traceability throughout the supply chain.

Levofloxacin Olikla is used in ophthalmology to treat bacterial infections of the eye and surrounding tissues.

- Bacterial conjunctivitis: reduces bacterial load, alleviates redness and discharge, promoting rapid symptom resolution. - Corneal ulcer: eradicates causative organisms, facilitating corneal healing and preventing scarring. - Post‑operative ocular infection: prevents bacterial colonisation after eye surgery, supporting uncomplicated recovery. - Keratitis: eliminates pathogens causing corneal inflammation, aiding visual recovery.

Common Side Effects: - Eye irritation or burning sensation - Redness of the conjunctiva - Foreign body sensation - Increased tearing - Blurred vision - Mild headache

Serious or Rare Side Effects: - Severe allergic reaction (angioedema, anaphylaxis) - Corneal ulcer worsening - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Significant ocular inflammation - Systemic hypersensitivity (rash, fever) - Vision loss due to retinal toxicity

Levofloxacin Olikla should be used with caution in the following situations: - Allergy assessment: avoid if known hypersensitivity to fluoroquinolones. - Contact lens wear: discontinue lens use during treatment to reduce irritation. - Pregnancy and lactation: safety unknown; prescribe only if benefits outweigh potential risks. - Systemic absorption: monitor patients with tendon disorders for signs of tendonitis. - Drug interactions: avoid concurrent use of other ophthalmic antibiotics unless directed. - Store at below 25°C: keep in the original container, protect from light and moisture.

Levofloxacin Olikla may interact with other ophthalmic or systemic agents.

Major Interactions (Avoid): - Systemic fluoroquinolones: increased risk of additive toxicity. - Corticosteroid eye drops: may mask infection signs and delay healing.

Moderate Interactions (Monitor Closely): - Anticholinergic eye drops: possible alteration of pupil response. - Non‑steroidal anti‑inflammatory eye drops: may delay corneal epithelial repair. - Herbal supplements containing quinine: potential pharmacodynamic interaction.